1-4 of 4
Graham P. Mead, PhD
Close
Sort by
Journal Articles

Monoclonal Gammopathy as a Determinant of Adverse Outcomes in Patients with Chronic Kidney Disease.

Colin A. Hutchison, MBChB, John Townend, MBChB, MD, Graham P. Mead, PhD, Katie Chandler, BSc, Jo Harper, BSc, Arthur R. Bradwell, MBChB, FRCP, FRCPath, Rosetta Zakeri, MBChB, Paul Cockwell, MBChB, PhD
Journal: Blood
Blood (2006) 108 (11): 5053.
https://doi.org/10.1182/blood.V108.11.5053.5053
Published: 2006
Journal Articles

Rapid Removal of Free Light Chains from Serum by Hemodialysis for Patients with Myeloma Kidney.

Arthur R. Bradwell, MB, ChB, FRCP, Neil D. Evans, PhD, Mike J. Chappell, PhD, Paul Cockwell, FRCP, Steven D. Reid, PhD, John Harrison, Colin Hutchison, MRCP, Graham P. Mead, PhD
Journal: Blood
Blood (2005) 106 (11): 3482.
https://doi.org/10.1182/blood.V106.11.3482.3482
Published: 2005
Journal Articles

Correlation of Serum Free Light Chains and Bone Marrow Plasma Cell Infiltration in Multiple Myeloma.

Graham P. Mead, PhD, Steven D. Reid, PhD, Bradley M. Augustson, MB;BS, Mark T. Drayson, MB;BS, Arthur R. Bradwell, MD, J. Anthony Child, MD
Journal: Blood
Blood (2004) 104 (11): 4865.
https://doi.org/10.1182/blood.V104.11.4865.4865
Published: 2004
Journal Articles

Serum Free Light Chain Levels in Asymptomatic Myeloma.

Bradley M. Augustson, MB;BS, Steven D. Reid, PhD, Graham P. Mead, PhD, Mark T. Drayson, PhD, J. Anthony Child, MD, Arthur R. Bradwell, MD
Journal: Blood
Blood (2004) 104 (11): 4880.
https://doi.org/10.1182/blood.V104.11.4880.4880
Published: 2004